UroGen Pharma URGN Q1 2025 Annual earnings
Reported May 12, 2025 · Before market open
Revenue$20.3MMiss by $3.0M
EPS-$0.92Miss by $0.09
Revenue estimate$23.3M
EPS estimate-$0.83
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$63.5M
EPS estimate-$0.27
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment UroGen Pharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did UroGen Pharma report Q1 2025 earnings?
- UroGen Pharma (URGN) reported Q1 2025 earnings on May 12, 2025 before market open.
- What were UroGen Pharma's Q1 2025 revenue and EPS?
- UroGen Pharma reported revenue of $20.3M and eps of $-0.92 for Q1 2025.
- Did UroGen Pharma beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $23.3M by $3.0M. EPS missed the consensus estimate of $-0.83 by $0.09.
- How did UroGen Pharma's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 7.8% from $18.8M a year earlier and eps grew 5.2% from $-0.97.
- Where can I find UroGen Pharma's Q1 2025 SEC filings?
- You can read the 10-K/A periodic report (0001437749-25-013839) directly on SEC EDGAR. The filing index links above go to sec.gov.